A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA

被引：1301

作者：

CRAWFORD, ED

EISENBERGER, MA

MCLEOD, DG

SPAULDING, JT

BENSON, R

DORR, FA

BLUMENSTEIN, BA

DAVIS, MA

GOODMAN, PJ

机构：

[1] NCI, DIV CANC TREATMENT, CANC THERAPY EVALUAT PROGRAM, CLIN INVEST BRANCH, BETHESDA, MD 20205 USA

[2] SW ONCOL GRP, CTR STAT, SEATTLE, WA USA

[3] MAYO CLIN & MAYO GRAD SCH MED, DEPT UROL, N CENT CANC TREATMENT GRP, ROCHESTER, MN 55901 USA

[4] WALTER REED ARMY MED CTR, DEPT SURG, UROL SERV, WASHINGTON, DC 20307 USA

[5] UNIFORMED SERV UNIV HLTH SCI, NATL PROSTAT CANC PROJECT, BETHESDA, MD 20814 USA

[6] UNIV CALIF SAN FRANCISCO, DEPT UROL, NO CALIF ONCOL GRP, SAN FRANCISCO, CA 94143 USA

[7] FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA

[8] UNIV MARYLAND, DEPT MED, DIV MED ONCOL, BALTIMORE, MD 21201 USA

[9] UNIV MARYLAND, CTR CANC, MID ATLANTIC ONCOL PROGRAM, BALTIMORE, MD 21201 USA

来源：

关键词：

D O I：

10.1056/NEJM198908173210702

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：419 / 424

页数：6

共 35 条

[1] BRENDLER H, 1962, CANCER CHEMOTH REP, P323
[2] A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME
BROOKMEYER, R
CROWLEY, J
[J]. BIOMETRICS, 1982, 38 (01) : 29 - 41
[3] BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
[4] 2-C
[5] COFFEY DS, 1981, UROLOGY, V17, P17
[6] Crawford E D, 1987, Prog Clin Biol Res, V243A, P283
[7] THE ENDOCRINOLOGY AND DEVELOPMENTAL BIOLOGY OF THE PROSTATE
CUNHA, GR
DONJACOUR, AA
COOKE, PS
MEE, S
BIGSBY, RM
HIGGINS, SJ
SUGIMURA, Y
[J]. ENDOCRINE REVIEWS, 1987, 8 (03) : 338 - 362
[8] DRAGO JR, 1984, CANCER-AM CANCER SOC, V53, P1447, DOI 10.1002/1097-0142(19840401)53:7<1447::AID-CNCR2820530703>3.0.CO
[9] 2-G
[10] A REEVALUATION OF NONHORMONAL CYTO-TOXIC CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CARCINOMA
EISENBERGER, MA
SIMON, R
ODWYER, PJ
WITTES, RE
FRIEDMAN, MA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 827 - 841